サンプル依頼リスト カート
  • English
デフォルト表紙
市場調査レポート
商品コード
1352496

世界のTHR- β作動薬市場：考察と予測 (2029年まで)

Global THR- Beta Agonists Market Insights, Forecast to 2029

出版日
発行
QYResearch
ページ情報
英文 73 Pages
納期
2～3営業日
カスタマイズ可能
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.08円
世界のTHR- β作動薬市場：考察と予測 (2029年まで)
出版日: 2023年09月29日
発行: QYResearch
ページ情報: 英文 73 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

当レポートは、THR- β作動薬 (THR- β Agonists) 市場について調査しており、市場規模や動向・需要の予測、成長要因および課題の分析、タイプ・用途・企業・地域別の内訳、競合情勢、主要企業のプロファイルなどの情報を提供しています。

目次

第1章 レポート概要

  • 調査範囲
  • 市場分析：タイプ別
    • 世界のTHR- β作動薬の市場規模成長率：タイプ別, 2018 VS 2022 VS 2029
    • Specification Below 10mg
    • Specification 10-50mg
    • Specification Above 50mg
  • 市場：用途別
    • 世界のTHR- β作動薬の市場規模成長率：用途別, 2018 VS 2022 VS 2029
    • Metabolic Diseases
    • Cardiovascular Disease
    • Others
  • 前提条件と制限
  • 調査目的
  • 対象期間

第2章 世界の市場成長トレンド

  • 世界のTHR- β作動薬の市場展望 (2018-2029)
  • 世界のTHR- β作動薬の市場成長トレンド：地域別
    • THR- β作動薬 市場規模：地域別: 2018 VS 2022 VS 2029
    • THR- β作動薬の市場規模実績：地域別 (2018-2023)
    • THR- β作動薬の市場規模予測：地域別 (2024-2029)
  • THR- β作動薬 市場動向
    • THR- β作動薬 業界動向
    • THR- β作動薬 市場の促進要因
    • THR- β作動薬 市場の課題
    • THR- β作動薬 市場の抑制要因

第3章 競合情勢：主要企業別

  • 世界規模の売上高 THR- β作動薬 ：競合別
    • 世界のTHR- β作動薬の収益：企業別 (2018-2023)
    • 世界のTHR- β作動薬の収益シェア：企業別 (2018-2023)
  • 世界のTHR- β作動薬の市場シェア：企業タイプ別 (Tier 1, Tier 2, and Tier 3)
  • 世界の主要企業 THR- β作動薬, 売上高ランキング, 2021 VS 2022 VS 2023
  • 世界のTHR- β作動薬 市場集中度
    • 世界のTHR- β作動薬 市場集中度 (CR5 and HHI)
    • 世界の上位10・上位5企業： THR- β作動薬の収益 2022
  • 世界の主要企業 THR- β作動薬 本社 および提供地域
  • 世界の主要企業 THR- β作動薬, 製品およびアプリケーション
  • 世界の主要企業 THR- β作動薬, 業界参入時期
  • M&A, 拡張計画

第4章 THR- β作動薬 内訳データ：タイプ別

  • 世界のTHR- β作動薬の市場規模実績：タイプ別 (2018-2023)
  • 世界のTHR- β作動薬の市場規模予測：タイプ別 (2024-2029)

第5章 THR- β作動薬 内訳データ：用途別

  • 世界のTHR- β作動薬の市場規模実績：用途別 (2018-2023)
  • 世界のTHR- β作動薬の市場規模予測：用途別 (2024-2029)

第6章 北米

  • 北米のTHR- β作動薬 市場規模 (2018-2029)
  • 北米のTHR- β作動薬 市場規模：タイプ別
    • 北米のTHR- β作動薬 市場規模：タイプ別 (2018-2023)
    • 北米のTHR- β作動薬 市場規模：タイプ別 (2024-2029)
    • 北米のTHR- β作動薬の市場シェア：タイプ別 (2018-2029)
  • 北米のTHR- β作動薬 市場規模：用途別
    • 北米のTHR- β作動薬 市場規模：用途別 (2018-2023)
    • 北米のTHR- β作動薬 市場規模：用途別 (2024-2029)
    • 北米のTHR- β作動薬の市場シェア：用途別 (2018-2029)
  • 北米のTHR- β作動薬 市場規模：国別
    • 北米のTHR- β作動薬 市場規模：国別: 2018 VS 2022 VS 2029
    • 北米のTHR- β作動薬 市場規模：国別 (2018-2023)
    • 北米のTHR- β作動薬 市場規模：国別 (2024-2029)
    • 米国
    • カナダ

第7章 欧州

  • 欧州のTHR- β作動薬 市場規模 (2018-2029)
  • 欧州のTHR- β作動薬 市場規模：タイプ別
    • 欧州のTHR- β作動薬 市場規模：タイプ別 (2018-2023)
    • 欧州のTHR- β作動薬 市場規模：タイプ別 (2024-2029)
    • 欧州のTHR- β作動薬の市場シェア：タイプ別 (2018-2029)
  • 欧州のTHR- β作動薬 市場規模：用途別
    • 欧州のTHR- β作動薬 市場規模：用途別 (2018-2023)
    • 欧州のTHR- β作動薬 市場規模：用途別 (2024-2029)
    • 欧州のTHR- β作動薬の市場シェア：用途別 (2018-2029)
  • 欧州のTHR- β作動薬 市場規模：国別
    • 欧州のTHR- β作動薬 市場規模：国別: 2018 VS 2022 VS 2029
    • 欧州のTHR- β作動薬 市場規模：国別 (2018-2023)
    • 欧州のTHR- β作動薬 市場規模：国別 (2024-2029)
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • ロシア
    • 北欧

第8章 中国

  • 中国のTHR- β作動薬 市場規模 (2018-2029)
  • 中国のTHR- β作動薬 市場規模：タイプ別
    • 中国のTHR- β作動薬 市場規模：タイプ別 (2018-2023)
    • 中国のTHR- β作動薬 市場規模：タイプ別 (2024-2029)
    • 中国のTHR- β作動薬の市場シェア：タイプ別 (2018-2029)
  • 中国のTHR- β作動薬 市場規模：用途別
    • 中国のTHR- β作動薬 市場規模：用途別 (2018-2023)
    • 中国のTHR- β作動薬 市場規模：用途別 (2024-2029)
    • 中国のTHR- β作動薬の市場シェア：用途別 (2018-2029)

第9章 アジア（中国を除く）

  • アジア地域 THR- β作動薬 市場規模 (2018-2029)
  • アジア地域 THR- β作動薬 市場規模：タイプ別
    • アジア地域 THR- β作動薬 市場規模：タイプ別 (2018-2023)
    • アジア地域 THR- β作動薬 市場規模：タイプ別 (2024-2029)
    • アジア地域 THR- β作動薬の市場シェア：タイプ別 (2018-2029)
  • アジア地域 THR- β作動薬 市場規模：用途別
    • アジア地域 THR- β作動薬 市場規模：用途別 (2018-2023)
    • アジア地域 THR- β作動薬 市場規模：用途別 (2024-2029)
    • アジア地域 THR- β作動薬の市場シェア：用途別 (2018-2029)
  • アジア地域 THR- β作動薬 市場規模：地域別
    • アジア地域 THR- β作動薬 市場規模：地域別: 2018 VS 2022 VS 2029
    • アジア地域 THR- β作動薬 市場規模：地域別 (2018-2023)
    • アジア地域 THR- β作動薬 市場規模：地域別 (2024-2029)
    • 日本
    • 韓国
    • 台湾
    • 東南アジア
    • インド
    • オーストラリア

第10章 中近東・アフリカ・中南米

  • 中近東・アフリカ・中南米 THR- β作動薬 市場規模 (2018-2029)
  • 中近東・アフリカ・中南米 THR- β作動薬 市場規模：タイプ別
    • 中近東・アフリカ・中南米 THR- β作動薬 市場規模：タイプ別 (2018-2023)
    • 中近東・アフリカ・中南米 THR- β作動薬 市場規模：タイプ別 (2024-2029)
    • 中近東・アフリカ・中南米 THR- β作動薬の市場シェア：タイプ別 (2018-2029)
  • 中近東・アフリカ・中南米 THR- β作動薬 市場規模：用途別
    • 中近東・アフリカ・中南米 THR- β作動薬 市場規模：用途別 (2018-2023)
    • 中近東・アフリカ・中南米 THR- β作動薬 市場規模：用途別 (2024-2029)
    • 中近東・アフリカ・中南米 THR- β作動薬の市場シェア：用途別 (2018-2029)
  • 中近東・アフリカ・中南米 THR- β作動薬 市場規模：国別
    • 中近東・アフリカ・中南米 THR- β作動薬 市場規模：国別: 2018 VS 2022 VS 2029
    • 中近東・アフリカ・中南米 THR- β作動薬 市場規模：国別 (2018-2023)
    • 中近東・アフリカ・中南米 THR- β作動薬 市場規模：国別 (2024-2029)
    • ブラジル
    • メキシコ
    • トルコ
    • サウジアラビア
    • イスラエル
    • 湾岸協力理事会諸国

第11章 主要企業のプロファイル

  • Madrigal Pharmaceuticals
  • Terns Pharmaceuticals
  • Ascletis
  • Haisco Pharmaceutical Group

第12章 アナリストによる分析/結論

第13章 付録

図表

List of Tables

  • Table 1. Global THR- β Agonists Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2029
  • Table 2. Key Players of Specification Below 10mg
  • Table 3. Key Players of Specification 10-50mg
  • Table 4. Key Players of Specification Above 50mg
  • Table 5. Global THR- β Agonists Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2029
  • Table 6. Global THR- β Agonists Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
  • Table 7. Global THR- β Agonists Market Size by Region (2018-2023) & (US$ Million)
  • Table 8. Global THR- β Agonists Market Share by Region (2018-2023)
  • Table 9. Global THR- β Agonists Forecasted Market Size by Region (2024-2029) & (US$ Million)
  • Table 10. Global THR- β Agonists Market Share by Region (2024-2029)
  • Table 11. THR- β Agonists Market Trends
  • Table 12. THR- β Agonists Market Drivers
  • Table 13. THR- β Agonists Market Challenges
  • Table 14. THR- β Agonists Market Restraints
  • Table 15. Global THR- β Agonists Revenue by Players (2018-2023) & (US$ Million)
  • Table 16. Global THR- β Agonists Revenue Share by Players (2018-2023)
  • Table 17. Global Top THR- β Agonists by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in THR- β Agonists as of 2022)
  • Table 18. Global THR- β Agonists Industry Ranking 2021 VS 2022 VS 2023
  • Table 19. Global 5 Largest Players Market Share by THR- β Agonists Revenue (CR5 and HHI) & (2018-2023)
  • Table 20. Global Key Players of THR- β Agonists, Headquarters and Area Served
  • Table 21. Global Key Players of THR- β Agonists, Product and Application
  • Table 22. Global Key Players of THR- β Agonists, Product and Application
  • Table 23. Mergers & Acquisitions, Expansion Plans
  • Table 24. Global THR- β Agonists Market Size by Type (2018-2023) & (US$ Million)
  • Table 25. Global THR- β Agonists Revenue Market Share by Type (2018-2023)
  • Table 26. Global THR- β Agonists Forecasted Market Size by Type (2024-2029) & (US$ Million)
  • Table 27. Global THR- β Agonists Revenue Market Share by Type (2024-2029)
  • Table 28. Global THR- β Agonists Market Size by Application (2018-2023) & (US$ Million)
  • Table 29. Global THR- β Agonists Revenue Share by Application (2018-2023)
  • Table 30. Global THR- β Agonists Forecasted Market Size by Application (2024-2029) & (US$ Million)
  • Table 31. Global THR- β Agonists Revenue Share by Application (2024-2029)
  • Table 32. North America THR- β Agonists Market Size by Type (2018-2023) & (US$ Million)
  • Table 33. North America THR- β Agonists Market Size by Type (2024-2029) & (US$ Million)
  • Table 34. North America THR- β Agonists Market Size by Application (2018-2023) & (US$ Million)
  • Table 35. North America THR- β Agonists Market Size by Application (2024-2029) & (US$ Million)
  • Table 36. North America THR- β Agonists Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
  • Table 37. North America THR- β Agonists Market Size by Country (2018-2023) & (US$ Million)
  • Table 38. North America THR- β Agonists Market Size by Country (2024-2029) & (US$ Million)
  • Table 39. Europe THR- β Agonists Market Size by Type (2018-2023) & (US$ Million)
  • Table 40. Europe THR- β Agonists Market Size by Type (2024-2029) & (US$ Million)
  • Table 41. Europe THR- β Agonists Market Size by Application (2018-2023) & (US$ Million)
  • Table 42. Europe THR- β Agonists Market Size by Application (2024-2029) & (US$ Million)
  • Table 43. Europe THR- β Agonists Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
  • Table 44. Europe THR- β Agonists Market Size by Country (2018-2023) & (US$ Million)
  • Table 45. Europe THR- β Agonists Market Size by Country (2024-2029) & (US$ Million)
  • Table 46. China THR- β Agonists Market Size by Type (2018-2023) & (US$ Million)
  • Table 47. China THR- β Agonists Market Size by Type (2024-2029) & (US$ Million)
  • Table 48. China THR- β Agonists Market Size by Application (2018-2023) & (US$ Million)
  • Table 49. China THR- β Agonists Market Size by Application (2024-2029) & (US$ Million)
  • Table 50. Asia THR- β Agonists Market Size by Type (2018-2023) & (US$ Million)
  • Table 51. Asia THR- β Agonists Market Size by Type (2024-2029) & (US$ Million)
  • Table 52. Asia THR- β Agonists Market Size by Application (2018-2023) & (US$ Million)
  • Table 53. Asia THR- β Agonists Market Size by Application (2024-2029) & (US$ Million)
  • Table 54. Asia THR- β Agonists Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
  • Table 55. Asia THR- β Agonists Market Size by Region (2018-2023) & (US$ Million)
  • Table 56. Asia THR- β Agonists Market Size by Region (2024-2029) & (US$ Million)
  • Table 57. Middle East, Africa, and Latin America THR- β Agonists Market Size by Type (2018-2023) & (US$ Million)
  • Table 58. Middle East, Africa, and Latin America THR- β Agonists Market Size by Type (2024-2029) & (US$ Million)
  • Table 59. Middle East, Africa, and Latin America THR- β Agonists Market Size by Application (2018-2023) & (US$ Million)
  • Table 60. Middle East, Africa, and Latin America THR- β Agonists Market Size by Application (2024-2029) & (US$ Million)
  • Table 61. Middle East, Africa, and Latin America THR- β Agonists Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
  • Table 62. Middle East, Africa, and Latin America THR- β Agonists Market Size by Country (2018-2023) & (US$ Million)
  • Table 63. Middle East, Africa, and Latin America THR- β Agonists Market Size by Country (2024-2029) & (US$ Million)
  • Table 64. Madrigal Pharmaceuticals Company Details
  • Table 65. Madrigal Pharmaceuticals Business Overview
  • Table 66. Madrigal Pharmaceuticals THR- β Agonists Product
  • Table 67. Madrigal Pharmaceuticals Revenue in THR- β Agonists Business (2018-2023) & (US$ Million)
  • Table 68. Madrigal Pharmaceuticals Recent Developments
  • Table 69. Terns Pharmaceuticals Company Details
  • Table 70. Terns Pharmaceuticals Business Overview
  • Table 71. Terns Pharmaceuticals THR- β Agonists Product
  • Table 72. Terns Pharmaceuticals Revenue in THR- β Agonists Business (2018-2023) & (US$ Million)
  • Table 73. Terns Pharmaceuticals Recent Developments
  • Table 74. Ascletis Company Details
  • Table 75. Ascletis Business Overview
  • Table 76. Ascletis THR- β Agonists Product
  • Table 77. Ascletis Revenue in THR- β Agonists Business (2018-2023) & (US$ Million)
  • Table 78. Ascletis Recent Developments
  • Table 79. Haisco Pharmaceutical Group Company Details
  • Table 80. Haisco Pharmaceutical Group Business Overview
  • Table 81. Haisco Pharmaceutical Group THR- β Agonists Product
  • Table 82. Haisco Pharmaceutical Group Revenue in THR- β Agonists Business (2018-2023) & (US$ Million)
  • Table 83. Haisco Pharmaceutical Group Recent Developments
  • Table 84. Research Programs/Design for This Report
  • Table 85. Key Data Information from Secondary Sources
  • Table 86. Key Data Information from Primary Sources

List of Figures

  • Figure 1. Global THR- β Agonists Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
  • Figure 2. Global THR- β Agonists Market Share by Type: 2022 VS 2029
  • Figure 3. Specification Below 10mg Features
  • Figure 4. Specification 10-50mg Features
  • Figure 5. Specification Above 50mg Features
  • Figure 6. Global THR- β Agonists Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
  • Figure 7. Global THR- β Agonists Market Share by Application: 2022 VS 2029
  • Figure 8. Metabolic Diseases Case Studies
  • Figure 9. Cardiovascular Disease Case Studies
  • Figure 10. Others Case Studies
  • Figure 11. THR- β Agonists Report Years Considered
  • Figure 12. Global THR- β Agonists Market Size (US$ Million), Year-over-Year: 2018-2029
  • Figure 13. Global THR- β Agonists Market Size, (US$ Million), 2018 VS 2022 VS 2029
  • Figure 14. Global THR- β Agonists Market Share by Region: 2022 VS 2029
  • Figure 15. Global THR- β Agonists Market Share by Players in 2022
  • Figure 16. Global Top THR- β Agonists Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in THR- β Agonists as of 2022)
  • Figure 17. The Top 10 and 5 Players Market Share by THR- β Agonists Revenue in 2022
  • Figure 18. North America THR- β Agonists Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 19. North America THR- β Agonists Market Share by Type (2018-2029)
  • Figure 20. North America THR- β Agonists Market Share by Application (2018-2029)
  • Figure 21. North America THR- β Agonists Market Share by Country (2018-2029)
  • Figure 22. United States THR- β Agonists Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 23. Canada THR- β Agonists Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 24. Europe THR- β Agonists Market Size YoY (2018-2029) & (US$ Million)
  • Figure 25. Europe THR- β Agonists Market Share by Type (2018-2029)
  • Figure 26. Europe THR- β Agonists Market Share by Application (2018-2029)
  • Figure 27. Europe THR- β Agonists Market Share by Country (2018-2029)
  • Figure 28. Germany THR- β Agonists Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 29. France THR- β Agonists Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 30. U.K. THR- β Agonists Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 31. Italy THR- β Agonists Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 32. Russia THR- β Agonists Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 33. Nordic Countries THR- β Agonists Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 34. China THR- β Agonists Market Size YoY (2018-2029) & (US$ Million)
  • Figure 35. China THR- β Agonists Market Share by Type (2018-2029)
  • Figure 36. China THR- β Agonists Market Share by Application (2018-2029)
  • Figure 37. Asia THR- β Agonists Market Size YoY (2018-2029) & (US$ Million)
  • Figure 38. Asia THR- β Agonists Market Share by Type (2018-2029)
  • Figure 39. Asia THR- β Agonists Market Share by Application (2018-2029)
  • Figure 40. Asia THR- β Agonists Market Share by Region (2018-2029)
  • Figure 41. Japan THR- β Agonists Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 42. South Korea THR- β Agonists Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 43. China Taiwan THR- β Agonists Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 44. Southeast Asia THR- β Agonists Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 45. India THR- β Agonists Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 46. Australia THR- β Agonists Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 47. Middle East, Africa, and Latin America THR- β Agonists Market Size YoY (2018-2029) & (US$ Million)
  • Figure 48. Middle East, Africa, and Latin America THR- β Agonists Market Share by Type (2018-2029)
  • Figure 49. Middle East, Africa, and Latin America THR- β Agonists Market Share by Application (2018-2029)
  • Figure 50. Middle East, Africa, and Latin America THR- β Agonists Market Share by Country (2018-2029)
  • Figure 51. Brazil THR- β Agonists Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 52. Mexico THR- β Agonists Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 53. Turkey THR- β Agonists Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 54. Saudi Arabia THR- β Agonists Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 55. Israel THR- β Agonists Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 56. GCC Countries THR- β Agonists Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 57. Madrigal Pharmaceuticals Revenue Growth Rate in THR- β Agonists Business (2018-2023)
  • Figure 58. Terns Pharmaceuticals Revenue Growth Rate in THR- β Agonists Business (2018-2023)
  • Figure 59. Ascletis Revenue Growth Rate in THR- β Agonists Business (2018-2023)
  • Figure 60. Haisco Pharmaceutical Group Revenue Growth Rate in THR- β Agonists Business (2018-2023)
  • Figure 61. Bottom-up and Top-down Approaches for This Report
  • Figure 62. Data Triangulation
  • Figure 63. Key Executives Interviewed
目次

This research report focuses on the THR- β Agonists Market. It analyzes market size, trends and demand forecasts, as well as growth factors and challenges. The report provides market data breakdowns by type, application, company, and region, in addition to competitive landscape and key company profiles.

TABLE OF CONTENTS

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Market Analysis by Type
    • 1.2.1 Global THR- β Agonists Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
    • 1.2.2 Specification Below 10mg
    • 1.2.3 Specification 10-50mg
    • 1.2.4 Specification Above 50mg
  • 1.3 Market by Application
    • 1.3.1 Global THR- β Agonists Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
    • 1.3.2 Metabolic Diseases
    • 1.3.3 Cardiovascular Disease
    • 1.3.4 Others
  • 1.4 Assumptions and Limitations
  • 1.5 Study Objectives
  • 1.6 Years Considered

2 Global Growth Trends

  • 2.1 Global THR- β Agonists Market Perspective (2018-2029)
  • 2.2 Global THR- β Agonists Growth Trends by Region
    • 2.2.1 THR- β Agonists Market Size by Region: 2018 VS 2022 VS 2029
    • 2.2.2 THR- β Agonists Historic Market Size by Region (2018-2023)
    • 2.2.3 THR- β Agonists Forecasted Market Size by Region (2024-2029)
  • 2.3 THR- β Agonists Market Dynamics
    • 2.3.1 THR- β Agonists Industry Trends
    • 2.3.2 THR- β Agonists Market Drivers
    • 2.3.3 THR- β Agonists Market Challenges
    • 2.3.4 THR- β Agonists Market Restraints

3 Competition Landscape by Key Players

  • 3.1 Global Revenue THR- β Agonists by Players
    • 3.1.1 Global THR- β Agonists Revenue by Players (2018-2023)
    • 3.1.2 Global THR- β Agonists Revenue Market Share by Players (2018-2023)
  • 3.2 Global THR- β Agonists Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
  • 3.3 Global Key Players of THR- β Agonists, Ranking by Revenue, 2021 VS 2022 VS 2023
  • 3.4 Global THR- β Agonists Market Concentration Ratio
    • 3.4.1 Global THR- β Agonists Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Global Top 10 and Top 5 Companies by THR- β Agonists Revenue in 2022
  • 3.5 Global Key Players of THR- β Agonists Head office and Area Served
  • 3.6 Global Key Players of THR- β Agonists, Product and Application
  • 3.7 Global Key Players of THR- β Agonists, Date of Enter into This Industry
  • 3.8 Mergers & Acquisitions, Expansion Plans

4 THR- β Agonists Breakdown Data by Type

  • 4.1 Global THR- β Agonists Historic Market Size by Type (2018-2023)
  • 4.2 Global THR- β Agonists Forecasted Market Size by Type (2024-2029)

5 THR- β Agonists Breakdown Data by Application

  • 5.1 Global THR- β Agonists Historic Market Size by Application (2018-2023)
  • 5.2 Global THR- β Agonists Forecasted Market Size by Application (2024-2029)

6 North America

  • 6.1 North America THR- β Agonists Market Size (2018-2029)
  • 6.2 North America THR- β Agonists Market Size by Type
    • 6.2.1 North America THR- β Agonists Market Size by Type (2018-2023)
    • 6.2.2 North America THR- β Agonists Market Size by Type (2024-2029)
    • 6.2.3 North America THR- β Agonists Market Share by Type (2018-2029)
  • 6.3 North America THR- β Agonists Market Size by Application
    • 6.3.1 North America THR- β Agonists Market Size by Application (2018-2023)
    • 6.3.2 North America THR- β Agonists Market Size by Application (2024-2029)
    • 6.3.3 North America THR- β Agonists Market Share by Application (2018-2029)
  • 6.4 North America THR- β Agonists Market Size by Country
    • 6.4.1 North America THR- β Agonists Market Size by Country: 2018 VS 2022 VS 2029
    • 6.4.2 North America THR- β Agonists Market Size by Country (2018-2023)
    • 6.4.3 North America THR- β Agonists Market Size by Country (2024-2029)
    • 6.4.4 United States
    • 6.4.5 Canada

7 Europe

  • 7.1 Europe THR- β Agonists Market Size (2018-2029)
  • 7.2 Europe THR- β Agonists Market Size by Type
    • 7.2.1 Europe THR- β Agonists Market Size by Type (2018-2023)
    • 7.2.2 Europe THR- β Agonists Market Size by Type (2024-2029)
    • 7.2.3 Europe THR- β Agonists Market Share by Type (2018-2029)
  • 7.3 Europe THR- β Agonists Market Size by Application
    • 7.3.1 Europe THR- β Agonists Market Size by Application (2018-2023)
    • 7.3.2 Europe THR- β Agonists Market Size by Application (2024-2029)
    • 7.3.3 Europe THR- β Agonists Market Share by Application (2018-2029)
  • 7.4 Europe THR- β Agonists Market Size by Country
    • 7.4.1 Europe THR- β Agonists Market Size by Country: 2018 VS 2022 VS 2029
    • 7.4.2 Europe THR- β Agonists Market Size by Country (2018-2023)
    • 7.4.3 Europe THR- β Agonists Market Size by Country (2024-2029)
    • 7.4.3 Germany
    • 7.4.4 France
    • 7.4.5 U.K.
    • 7.4.6 Italy
    • 7.4.7 Russia
    • 7.4.8 Nordic Countries

8 China

  • 8.1 China THR- β Agonists Market Size (2018-2029)
  • 8.2 China THR- β Agonists Market Size by Type
    • 8.2.1 China THR- β Agonists Market Size by Type (2018-2023)
    • 8.2.2 China THR- β Agonists Market Size by Type (2024-2029)
    • 8.2.3 China THR- β Agonists Market Share by Type (2018-2029)
  • 8.3 China THR- β Agonists Market Size by Application
    • 8.3.1 China THR- β Agonists Market Size by Application (2018-2023)
    • 8.3.2 China THR- β Agonists Market Size by Application (2024-2029)
    • 8.3.3 China THR- β Agonists Market Share by Application (2018-2029)

9 Asia (excluding China)

  • 9.1 Asia THR- β Agonists Market Size (2018-2029)
  • 9.2 Asia THR- β Agonists Market Size by Type
    • 9.2.1 Asia THR- β Agonists Market Size by Type (2018-2023)
    • 9.2.2 Asia THR- β Agonists Market Size by Type (2024-2029)
    • 9.2.3 Asia THR- β Agonists Market Share by Type (2018-2029)
  • 9.3 Asia THR- β Agonists Market Size by Application
    • 9.3.1 Asia THR- β Agonists Market Size by Application (2018-2023)
    • 9.3.2 Asia THR- β Agonists Market Size by Application (2024-2029)
    • 9.3.3 Asia THR- β Agonists Market Share by Application (2018-2029)
  • 9.4 Asia THR- β Agonists Market Size by Region
    • 9.4.1 Asia THR- β Agonists Market Size by Region: 2018 VS 2022 VS 2029
    • 9.4.2 Asia THR- β Agonists Market Size by Region (2018-2023)
    • 9.4.3 Asia THR- β Agonists Market Size by Region (2024-2029)
    • 9.4.4 Japan
    • 9.4.5 South Korea
    • 9.4.6 China Taiwan
    • 9.4.7 Southeast Asia
    • 9.4.8 India
    • 9.4.9 Australia

10 Middle East, Africa, and Latin America

  • 10.1 Middle East, Africa, and Latin America THR- β Agonists Market Size (2018-2029)
  • 10.2 Middle East, Africa, and Latin America THR- β Agonists Market Size by Type
    • 10.2.1 Middle East, Africa, and Latin America THR- β Agonists Market Size by Type (2018-2023)
    • 10.2.2 Middle East, Africa, and Latin America THR- β Agonists Market Size by Type (2024-2029)
    • 10.2.3 Middle East, Africa, and Latin America THR- β Agonists Market Share by Type (2018-2029)
  • 10.3 Middle East, Africa, and Latin America THR- β Agonists Market Size by Application
    • 10.3.1 Middle East, Africa, and Latin America THR- β Agonists Market Size by Application (2018-2023)
    • 10.3.2 Middle East, Africa, and Latin America THR- β Agonists Market Size by Application (2024-2029)
    • 10.3.3 Middle East, Africa, and Latin America THR- β Agonists Market Share by Application (2018-2029)
  • 10.4 Middle East, Africa, and Latin America THR- β Agonists Market Size by Country
    • 10.4.1 Middle East, Africa, and Latin America THR- β Agonists Market Size by Country: 2018 VS 2022 VS 2029
    • 10.4.2 Middle East, Africa, and Latin America THR- β Agonists Market Size by Country (2018-2023)
    • 10.4.3 Middle East, Africa, and Latin America THR- β Agonists Market Size by Country (2024-2029)
    • 10.4.4 Brazil
    • 10.4.5 Mexico
    • 10.4.6 Turkey
    • 10.4.7 Saudi Arabia
    • 10.4.8 Israel
    • 10.4.9 GCC Countries

11 Key Players Profiles

  • 11.1 Madrigal Pharmaceuticals
    • 11.1.1 Madrigal Pharmaceuticals Company Details
    • 11.1.2 Madrigal Pharmaceuticals Business Overview
    • 11.1.3 Madrigal Pharmaceuticals THR- β Agonists Introduction
    • 11.1.4 Madrigal Pharmaceuticals Revenue in THR- β Agonists Business (2018-2023)
    • 11.1.5 Madrigal Pharmaceuticals Recent Developments
  • 11.2 Terns Pharmaceuticals
    • 11.2.1 Terns Pharmaceuticals Company Details
    • 11.2.2 Terns Pharmaceuticals Business Overview
    • 11.2.3 Terns Pharmaceuticals THR- β Agonists Introduction
    • 11.2.4 Terns Pharmaceuticals Revenue in THR- β Agonists Business (2018-2023)
    • 11.2.5 Terns Pharmaceuticals Recent Developments
  • 11.3 Ascletis
    • 11.3.1 Ascletis Company Details
    • 11.3.2 Ascletis Business Overview
    • 11.3.3 Ascletis THR- β Agonists Introduction
    • 11.3.4 Ascletis Revenue in THR- β Agonists Business (2018-2023)
    • 11.3.5 Ascletis Recent Developments
  • 11.4 Haisco Pharmaceutical Group
    • 11.4.1 Haisco Pharmaceutical Group Company Details
    • 11.4.2 Haisco Pharmaceutical Group Business Overview
    • 11.4.3 Haisco Pharmaceutical Group THR- β Agonists Introduction
    • 11.4.4 Haisco Pharmaceutical Group Revenue in THR- β Agonists Business (2018-2023)
    • 11.4.5 Haisco Pharmaceutical Group Recent Developments

12 Analyst's Viewpoints/Conclusions

13 Appendix

  • 13.1 Research Methodology
    • 13.1.1 Methodology/Research Approach
    • 13.1.2 Data Source
  • 13.2 Disclaimer
  • 13.3 Author Details